Q4 2019 argenx SE Earnings Call Transcript
Ladies and gentlemen, thank you for standing by, and welcome to argenx Full Year 2019 Financial Results and Fourth Quarter Business Update Conference Call. (Operator Instructions)
I would like to introduce Beth DelGiacco, Vice President of Investor Relations at argenx. Thank you. Please go ahead.
Thank you, operator. A press release with our fourth quarter business update and full year 2019 financial results was issued earlier today and can be found on the News and Events section of our website.
Before we begin, I'd like to remind you on Slide 2 that forward-looking statements may be presented during this call. These may include statements about our future expectations, clinical development, regulatory time lines, the potential success of our product candidates, financial projections and upcoming milestones. Actual results may differ materially from those indicated by these statements. Argenx is not under any obligation to update statements regarding the future or to conform those statements in
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |